About Half of Heavy Cannabis Users Experience Withdrawal. This Meta-Analysis Measured It.

This was the first meta-analysis to estimate how common cannabis withdrawal syndrome actually is. Pooling 23 studies with 27,461 participants who had regular or dependent cannabis use, the researchers found a prevalence of 47% — meaning roughly half of heavy users experienced clinically significant withdrawal when they stopped.

The withdrawal symptoms weren't subtle. The most commonly reported were irritability, nervousness or anxiety, sleep difficulty, decreased appetite, restlessness, depressed mood, and anger or aggression. These typically appeared within the first week of cessation and resolved within 2-4 weeks.

Several factors predicted higher withdrawal rates. People with more severe cannabis use disorder, those using more frequently, and those with comorbid mental health conditions were more likely to experience withdrawal. The 47% figure also masked a wide range across studies — from under 20% in some samples to over 70% in others, reflecting differences in how withdrawal was measured and who was studied.

For years, cannabis withdrawal was dismissed or minimized — both in popular culture and in clinical settings. This meta-analysis put a hard number on it: 47%. That's not everyone, but it's not a small minority either. Roughly half of heavy users will experience a clinically recognizable withdrawal syndrome when they stop.

This matters for anyone trying to quit. Knowing that irritability, insomnia, and anxiety during the first two weeks are a documented medical phenomenon — not a personal weakness — changes how people approach cessation. It also strengthens the clinical case for cannabis use disorder as a real condition with measurable physiological features.